Why are all productions at Diatec Monoclonals performed in vitro?
After Khler and Milstein’s discovery of hybridomas producing monoclonal antibodies in 1975, production was initially done in the ascitic fluid of production animals. Hollow fibre technology was developed over the same period, and has over the last decade given us an excellent alternative to using production animals. Due to animal welfare concerns, and the possibility of obtaining a pure product, without animal contaminants, with high batch to batch reproducibility, hollow fibre technology has proved to be a very reasonable choice. Read more. • Quality control at Diatec Monoclonals AS Diatec Monoclonals is certified according to the ISO9001:2000 standard. All products and services delivered from Diatec Monoclonals are according to this standard. Our procedures are documented through control plans, standard operation procedures and full historical records of procedures, ensuring full traceability and documentation of our products? high quality.
